Stock listing
VTVT Stock Price, News, Filings & Events — Vtv Therapeutics Inc.
Selected listing: VTVT · NASDAQ · USD · US
This page tracks Vtv Therapeutics Inc.'s VTVT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VTVT:NASDAQ. VTVT:NASDAQ is the stock-level entry point for investors researching Vtv Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vtv Therapeutics Inc. is a public company traded under the ticker VTVT in the American market. The company has a market capitalization of approximately $121 million. Vtv Therapeutics focuses on developing innovative therapies to address unmet medical needs.

- Ticker
- VTVT:NASDAQ
- Asset type
- Stock
- Market cap
- $126.4M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Vtv Therapeutics Inc. VTVT:NASDAQ stock context
This page tracks Vtv Therapeutics Inc.'s VTVT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VTVT:NASDAQ. VTVT:NASDAQ is the stock-level entry point for investors researching Vtv Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vtv Therapeutics Inc. is a public company traded under the ticker VTVT in the American market. The company has a market capitalization of approximately $121 million. Vtv Therapeutics focuses on developing innovative therapies to address unmet medical needs.
Latest news from Vtv Therapeutics Inc.
vTv Therapeutics to Participate in September Investor Conferences
September 2, 2026
VTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 6, 2026
VTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(4)
June 3, 2026
VTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 2, 2026
vTv Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 13, 2026
Research Vtv Therapeutics Inc.
Vtv Therapeutics Inc. investor report
Review AI stock analysis and investor report context for VTVT:NASDAQ.
Vtv Therapeutics Inc. company profile
View the public company page for Vtv Therapeutics Inc. on 6ix.
Vtv Therapeutics Inc. news
Read company news and market updates connected to Vtv Therapeutics Inc..
Vtv Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Vtv Therapeutics Inc..
Alternate listings
VTVT:BOATS
US · USD
Alternate listing for Vtv Therapeutics Inc.; the primary context on this page is VTVT:NASDAQ.
5VT0:FWB
DE · EUR
Alternate listing for Vtv Therapeutics Inc.; the primary context on this page is VTVT:NASDAQ.
A3EWXG:LS
DE · EUR
Alternate listing for Vtv Therapeutics Inc.; the primary context on this page is VTVT:NASDAQ.
5VT0:SWB
DE · EUR
Alternate listing for Vtv Therapeutics Inc.; the primary context on this page is VTVT:NASDAQ.
5VT0:TRADEGATE
DE · EUR
Alternate listing for Vtv Therapeutics Inc.; the primary context on this page is VTVT:NASDAQ.